Effect of Oral Procaterol on Postinfectious Persistent Cough

• Status: Unknown status
• Trial end date: 2018-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate the effectiveness of oral procaterol in treatment of non-asthmatic patients who suffer from persistent cough following upper respiratory tract infection (URTI).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mahidol University
• Collaborators: Thai Otsuka Pharmaceutical Co., Ltd.; Thai Otsuka Pharmaceutical Co.,Ltd.
• Treatments: Procaterol

Criteria

Inclusion Criteria:

1. Having persistent cough that lasts longer than 3 weeks following URTI

2. Currently being a non-smoker

3. Having normal spirometry (FEV1>or= 80% predicted)

4. Obtain consent form

Exclusion Criteria:

1. Having cough more than 8 weeks

2. Having history of allergic or intolerance to β2 agonist

3. Having diagnosis of asthma by physicians

4. Presence of wheeze or rhonchi on physical examination

5. Having radiographic evidence of pneumonia, tuberculosis or sinusitis

6. Having significant gastroesophageal reflux symptoms suggested by GERD-Q questionnaire (GERD-Q score > 8)

7. Currently taking ACE-inhibitor

8. Being active smokers

9. Refuse to participate in the study